Esophagogastric Cancer clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
The purpose of this study is to see whether the study drug, amivantamab, is an effective treatment for people with EGFR- or MET-amplified esophagogastric cancer. The researchers will also look at whether amivantamab is a safe treatment that causes few or mild side effects in participants.
Irvine, California and other locations